ULTIVUE
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use. It was founded in 2015 and headquartered in Cambridge, Massachusetts.
ULTIVUE
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ultivue.com
Total Employee:
51+
Status:
Active
Contact:
(781)883-1531
Email Addresses:
[email protected]
Total Funding:
110.58 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Content Delivery Network LetsEncrypt
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Juvenescence
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Strateos
Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.
TRex Bio
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series D - Ultivue
Applied Ventures
Applied Ventures investment in Series D - Ultivue
Tao Capital Partners
Tao Capital Partners investment in Series D - Ultivue
Ally Bridge Group
Ally Bridge Group investment in Series D - Ultivue
Pura Vida Investments
Pura Vida Investments investment in Series D - Ultivue
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Ultivue
Applied Ventures
Applied Ventures investment in Series C - Ultivue
6 Dimensions Capital
6 Dimensions Capital investment in Series C - Ultivue
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Ultivue
Yonghua Capital
Yonghua Capital investment in Series C - Ultivue
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-02 | Ultivue Announces New Executive Team Member - Nov 02, 2021 |
Official Site Inspections
http://www.ultivue.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.13 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ultivue"
HOME - Ultivue
OmniVUE™ panels with completely validated biomarkers offer complete flexibility in panel design so that researchers can assemble their panel of choice by selecting any combination of biomarkers from the core menu. With robust …See details»
Leadership - Ultivue
ANNOUNCEMENT: Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-OmicsSee details»
Ultivue - LinkedIn
Ultivue | 7,294 followers on LinkedIn. Profiling Cancer Biology | Spatial Proteomics | Multiplex Immunofluorescence Kits, Assay Development, Image Analysis | Ultivue recently merged with Vizgen to ...See details»
Vizgen and Ultivue Merge to Enable Deeper Insights …
Oct 9, 2024 The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified solutions in spatial multi-omics. ... Rob Carson, …See details»
Ultivue - Crunchbase Company Profile & Funding
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights
Oct 9, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights …
Oct 9, 2024 Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, and Ultivue, Inc., a market leader in multiplex proteomic biomarker detection and advanced AI …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
CAMBRIDGE, Mass., October 09, 2024--Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-OmicsSee details»
Ultivue Company Profile 2024: Valuation, Investors, Acquisition
Ultivue General Information Description. Developer of multiplex biomarker assays designed to help in tissue phenotyping and digital pathology. The company's assays integrate validated …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights …
Oct 9, 2024 The Vizgen-Ultivue merger brings together two established spatial biology companies, uniting Vizgen’s breakthrough MERFISH spatial genomics technology – including its MERSCOPE Ultra™ Spatial Imaging platform – with …See details»
Ultivue - Contacts, Employees, Board Members, Advisors & Alumni
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.See details»
Ultivue - Funding, Financials, Valuation & Investors - Crunchbase
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Ultivue Company Profile - Office Locations, Competitors ... - Craft
Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use. The company's patented technologies enable single …See details»
Working At Ultivue: Company Overview and Culture - Zippia
Mar 14, 2024 Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use. The company's patented technologies …See details»
Every Flavor Has a Story - Ultivue
Sep 13, 2021 Prior to joining Ultivue as CEO in January 2020, I had the unique opportunity to see the organization in action through a collaboration between my then employer, Definiens, …See details»
Ultivue and ZEISS to Co-Market Complete Solution for Spatial …
Oct 12, 2022 WHITE PLAINS, N.Y. and CAMBRIDGE, Mass., Oct. 12, 2022 /PRNewswire/ -- Carl Zeiss Microscopy, LLC, today announced that it has entered into an agreement with …See details»
Resource Center - Ultivue
Ultivue. FlexVUE, InSituPlex. Learn more. webinar . Living in a Spatial World: Characterizing the Immune Environment in Tumors. Angela Vasaturo, PhD; Lorcan Sherry, PhD ... Which best …See details»
Ultivue - VentureRadar
Ultivue's proprietary solutions will enable researchers and clinicians to realize the promise of personalized medicine through better matching of patients to therapeutic options. The …See details»
Points of VUE | Ultivue News
Nov 3, 2022 Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, announced its most recent equity capital raise. The …See details»